Science

New Study: CBD Does Not Effect Driving Skills

Responsible cannabis consumers recognize that operating a motor vehicle on a public roadway while being intoxicated by any substance, cannabis included, is not safe.

With that being said, just because someone has cannabis in their system does not automatically mean that they are too impaired to safely operate a motor vehicle.

That is demonstrated in the results of a recent study conducted in Australia. Below is more information about it via a news release from NORML:

Sydney, Australia: The oral administration of up to 1500 mg of CBD does not induce feelings of intoxication and is not associated with changes in simulated driving performance, according to data published in the Journal of Psychopharmacology.

A team of Australian researchers assessed the impact of varying dosages of CBD (ranging from 15 mg to 1500) versus placebo in 17 subjects. Study participants engaged in a series of simulated driving tests at approximately one hour and four hours after dosing. Investigators separately assessed subjects’ cognitive performance via their completion of a variety of computerized tasks. Participants were also asked whether they felt either “stoned” or “sedated” at any time during the trial.

Consistent with prior research, authors reported that CBD administration was not associated with either weaving or any other significant changes in simulated driving performance. Participants also failed to show any significant differences in either cognitive function or in their subjective feelings of well-being following CBD dosing.

Authors concluded: “The results of this study suggest that acute, oral CBD treatment at doses up to 1500 mg does not induce feelings of intoxication and is unlikely to impair cognitive function or driving performance. However, further research is required to confirm no effect of CBD on safety-sensitive tasks in the hours immediately post-treatment and with chronic administration.”

Full text of the study, “Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomized controlled trial,” appears in the Journal of Psychopharmacology. Additional information is available from NORML’s fact sheet, ‘Marijuana and Psychomotor Performance.’

This article first appeared on Internationalcbc.com and is syndicated here with special permission.

Frank Schuler

Patricia Miller is the Managing Editor for Cannabis & Tech Today. She covers science, technology, and policy shaping the legal cannabis industry. Miller is also an avid kayaker with a proclivity for picnicking. Follow her work on Twitter @_PMiller.

Recent Posts

Customer Data Drives Higher Revenues in the Cannabis Sector

To succeed in the cannabis industry, you have to be ahead of your competition and…

16 hours ago

New Study: Hemp Increases Cow Health and Reduces Stress

A federally funded study published in Scientific Reports suggests that hemp has similar effects on…

2 days ago

Missouri to Vote on Recreational Cannabis, Expungement Amendment

Nov. 8, Missouri residents will have the opportunity to vote on legalization of adult-use cannabis. …

3 days ago

Olivia Newton-John Gave a Voice to Those With Cancer and Shifted the Focus to the Life of Survivors

Alex Broom, University of Sydney Since news of Olivia Newton-John’s death this week, many have…

6 days ago

Cannabis May Be “Useful Treatment Strategy” for Fibromyalgia Patients

Fibromyalgia is a serious problem across the globe, affecting people of all ages. It is estimated that…

7 days ago

Cannabis Bongs: Different Types and How They Work

Are you considering trying out a bong for the first time but want to know…

1 week ago